Sign inJoin waitlistJoin the waitlist

Alexander Fuld

, Program Director · Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital

Credentials: · · · · · ·

History

Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
Present
Hematology · Geisel School of Medicine
Present
Geisel School of Medicine
Present

Hematology and Medical Oncology
2005–2008
Internal Medicine
2002–2005
Sidney Kimmel Medical College at Thomas Jefferson University
1998–2002
B.A. Art History, Dartmouth College 1997
1993–1997

Research

Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical Trial
JAMA Oncology · 2023 · 44 citations
Pemetrexed in advanced non-small-cell lung cancer
Review · Expert Opinion on Pharmacotherapy · 2010 · First of 3 authors · Corresponding · 36 citations
A phase I trial and in vitro studies combining ABT-751 with carboplatin in previously treated non-small cell lung cancer patients
Chemotherapy · 2012 · 30 citations

Konstantin Dragnev
3 papers
Frederick Lansigan
2 papers
JR
James Rigas
2 papers
Jimmy Ruiz
2 papers
Jorge Nieva
2 papers
Lisa Bellini
2 papers
Liza Villaruz
2 papers
SG
Steven Gore
2 papers
Theodore Iwashyna
2 papers
AC
Abigail Combs
1 paper · 1 as a fellow
AH
Alan Hartford
1 paper
Aman Chauhan
1 paper

Clinical trials

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2032
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2039
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2020–2027